Сычев, Д. Межлекарственные взаимодействия и полипрагмазия в практике врача / Д. Сычев, В. Отделенов, К. Данилина, Г. Аникин, С. Арсланбекова // Врач. - 2013. - № 5. - C. 5-9.
Сычев, Д. А. Полипрагмазия : взгляд клинического фармаколога / Д. А. Сычев, В. А. Отделенов, Н. М. Краснова, Е. С. Ильина // Терапевтический архив. - 2016. - Т. 88, № 12. - С. 94-102.
Титова, А. Р. Нерегламентированное (off-label) применение лекарственных препаратов в педиатрической практике : нерешенные проблемы / А. Р. Титова, И. Л. Асецкая, С. К. Зырянов, В. А. Поливанов // Педиатрическая фармакология. - 2015. - Т. 12, № 3. - С. 304-308.
Astrand, B. Avoiding Drug-Drug Interactions / B. Astrand // Chemotherapy. - 2009. - Vol. 55, № 4. - P. 215-220.
Bushardt, R. L. Polypharmacy : misleading, but manageable / R. L. Bushardt, E. B. Massey, T. W. Simpson, J. C. Ariail, K. N. Simpson // Clinical interventions in aging. - 2008. - Vol. 3, № 2. - P. 383-389.
Dai, D. Epidemiology of Polypharmacy and Potential Drug-Drug Interactions Among Pediatric Patients in ICUs of U.S. Children's Hospitals / D. Dai, J. A. Feinstein, W. Morrison, A. F. Zuppa, C. Feudtner // Pediatric Critical Care Medicine. - 2016. - Vol. 17, № 5. - P. e218-e228.
Davies, E. C. Adverse drug reactions in hospital in-patients : a prospective analysis of 3695 patient-episodes / E. C. Davies, C. F. Green, S. Taylor, P. R. Williamson, D. R. Mottram, M. Pirmohamed // PLoS ONE. - 2009. - Vol. 4, № 2. - P. e4439.
Drugs.com. Drug interaction checker. - Режим доступа: https://www.drugs.com/drug_interactions.html, свободный. - Заглавие с экрана. - Яз. англ. - Дата обращения : 22.12.2018.
Feinstein, J. Potential drug-drug interactions in infant, child, and adolescent patients in children's hospitals / J. Feinstein, D. Dai, W. Zhong, J. Freedman, C. Feudtner // Pediatrics. - 2015. - Vol. 135, № 1. - P. e99-e108.
Gnjidic, D. Polypharmacy cutoff and outcomes : five or more medicines were used to identify communitydwelling older men at risk of different adverse outcomes / D. Gnjidic, S. N. Hilmera, F. M. Blythc, V. Naganathanc,
Waitec, M. J. Seibelc, A. J. McLachland, R. G. Cummingc, D. J. Handelsmanc, D. G. Le Couteurc // Journal of Clinical Epidemiology. - 2012. - Vol. 65, № 9. - P. 989-995.
Hanlon, J. T. Potential drug-drug and drug-disease interactions in well-functioning community-dwelling older adults / J. T. Hanlon, S. Perera, A. B. Newman, J. M. Thorpe, J. M. Donohue, E. M. Simonsick, R. I. Shorr, D. C. Bauer, Z. A. Marcum // Journal of Clinical Pharmacy and Therapeutics. - 2017. - Vol. 42, № 2. - P. 228-233.
Leone, R. Identifying Adverse Drug Reactions Associated with Drug-Drug Interactions / R. Leone,
Magro, U. Moretti, P. Cutroneo, M. Moschini, D. Motola, M. Tuccori, A. Conforti // Drug Safety. - 2010. - Vol. 33, № 8. - P. 667-675.
Masnoon, N. What is polypharmacy? A systematic review of definitions / N. Masnoon, S. Shakib,
Kalisch-Ellett, G. E. Caughey // BmC geriatrics. - 2017. - Vol. 17, № 1. - P. 230.
Medscape. Drug interaction checker. - Режим доступа: https://reference.medscape.com/drug-
interactionchecker, свободный. - Заглавие с экрана. - Яз. англ. - Дата обращения : 22.12.2018.
Murtaza, G. Assessment of potential drug-drug interactions and its associated factors in the hospitalized cardiac patients / G. Murtaza, M. Y. G. Khan, S. Azhar, S. A. Khan, T. M. Khan // Saudi Pharmaceutical Journal. - 2015. - Vol. 24, № 2. - P. 220-225.
Wittich, C. M. Ten common questions (and their answers) about off-label drug use // C. M. Wittich,
M. Burkle, W. L. Lanier // Mayo Clinic proceedings. - 2012 - Vol. 87, № 10. - P. 982-990.
References
Astapova O., Syubaev R., Zhuravleva M., Sy'chev D., Engaly'cheva G., Vasil'ev A. Otsenka ratsional'nosti kombinirovannoy farmakoterapii [Evaluation of the efficiency of combined pharmacotherapy]. Vrach [The Doctor], 2014, no. 5, pp. 31-36.
Baranov, A. A. Rossiyskiy natsional'nyy pediatricheskiy formulyar [Russian National Formulary for Children]. Moscow, GEOTAR-media, 2009, 912 p.
Gosudarstvennyy reestr lekarstvennykh sredstv [State Register of Medicines]. Available at: http://grls.rosminzdrav.ru/grls.aspx (http://grls.rosminzdrav.ru/grls.aspx) (accessed 22 December 2018).
Martsevich, S. Yu., Navasardyan A. R., Komkova N. A. Naznachenie lekarstvennykh sredstv ne v soot- vetstvii s ofitsial'noy instruktsiey po meditsinskomu primeneniyu (off-label). Vozmozhnye prichiny, vidy i posledstviya. Pravovoe regulirovanie v Rossiyskoy Federatsii [Off-Label Prescribing. Possible Causes, Types and Consequences. Legal Regulation in the Russian Federation]. Ratsional'naya farmakoterapiya v kardiologii [Rational Pharmacotherapy in Cardiology], 2017, vol. 13, no. 5, pp. 667-674.
Otdelenov V. A., Novakova A. I., Karasev A. V., Yashina L. P., Payushchik S. A., Sychev D. A., Kleymenova E. B., Nazarenko G. I. Otsenka chastoty potentsial'no znachimykh mezhlekarstvennykh vzaimodeystviy u bol'nykh s polipragmaziey v mnogoprofil'nom statsionare [Estimation of the incidence of potentially significant drug-drug interactions in patients with polypharmacy in the general hospital]. Klinicheskaya farmakologiya i terapiya [Clinical Pharmacology and Therapy], 2012, vol. 21, no. 5, pp. 81-85.
Sychev D., Otdelenov V., Danilina K., Anikin G., Arslanbekova S. Mezhlekarstvennye vzaimodeystviya i polipragmaziya v praktike vracha [Drug interactions and polypragmasy in a physician's practice]. Vrach [The Doctor], 2013, no. 5, pp. 5-9.
Sychev D. A., Otdelenov V. A., Krasnova N. M., Il'ina E. S. Polipragmaziya: vzglyad klinicheskogo farma- kologa [Polypragmasy: A clinical pharmacologist's view]. Terapevticheskiy arkhiv [Therapeutic Archive], 2016, vol. 88, no. 12, pp. 94-102.
Titova, A. R., Asetskaya I. L., Zyryanov S. K., Polivanov V. A. Nereglamentirovannoe (off-label) primenenie lekarstvennykh preparatov v pediatricheskoy praktike: nereshennye problemy [Off-Label Drug Use in Pediatric Practice: Unsolved Problems]. Pediatricheskaya farmakologiya [Pediatric Pharmacology], 2015, vol. 12, no. 3, pp. 304-308.
Astrand B. Avoiding Drug-Drug Interactions. Chemotherapy, 2009, vol. 55, no. 4, pp. 215-220.
Bushardt R. L., Massey E. B., Simpson T. W., Ariail J. C., Simpson K. N. Polypharmacy : misleading, but manageable. Clinical interventions in aging, 2008, vol. 3, no. 2, pp. 383-389.
Dai D., Feinstein J. A., Morrison W., Zuppa A. F., Feudtner C. Epidemiology of Polypharmacy and Potential Drug-Drug Interactions Among Pediatric Patients in ICUs of U.S. Children's Hospitals. Pediatric Critical Care Medicine, 2016, vol. 17, no. 5, pp. e218-e228.
Davies E. C., Green C. F., Taylor S., Williamson P. R., Mottram D. R., Pirmohamed M. Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes. PLoS ONE, 2009, vol. 4, no. 2, pp. e4439.
Drugs.com. Drug interaction checker. Available at: https://www.drugs.com/drug_interactions.html (accessed 22 December 2018).
Feinstein J., Dai D., Zhong W., Freedman J., Feudtner C. Potential drug-drug interactions in infant, child, and adolescent patients in children's hospitals. Pediatrics, 2015, vol. 135, no. 1, pp. e99-e108.
Gnjidic D., Hilmera S. N., Blythc F. M., Naganathanc V., Waitec L., Seibelc M. J., McLachland A. J., Cummingc R. G., Handelsmanc D. J., Le Couteurc D. G. Polypharmacy cutoff and outcomes: five or more medicines were used to identify community-dwelling older men at risk of different adverse outcomes. Journal of Clinical Epidemiology, 2012, vol. 65, no. 9, pp. 989-995.
Hanlon J. T., Perera S., Newman A. B., Thorpe J. M., Donohue J. M., Simonsick E. M., Shorr R. I., Bauer D. C., Marcum Z. A. Potential drug-drug and drug-disease interactions in well-functioning community-dwelling older adults. Journal of Clinical Pharmacy and Therapeutics, 2017, vol. 42, no. 2, pp. 228-233.
Leone R., Magro L., Moretti U., Cutroneo P., Moschini M., Motola D., Tuccori M., Conforti A. Identifying Adverse Drug Reactions Associated with Drug-Drug Interactions. Drug Safety, 2010, vol. 33, no. 8, pp. 667-675.
Masnoon N. Shakib S., Kalisch-Ellett L., Caughey G. E. What is polypharmacy? A systematic review of definitions. BMC geriatrics, 2017, vol. 17, no. 1, pp. 230.
Medscape. Drug interaction checker. Available at: https://reference.medscape.com/drug-interactionchecker (accessed 22 December 2018).
Murtaza G. Khan M. Y. G., Azhar S., Khan S. A., Khan T. M. Assessment of potential drug-drug interactions and its associated factors in the hospitalized cardiac patients. Saudi Pharmaceutical Journal, 2015, vol. 24, no. 2, pp. 220-225.
Wittich C. M., Burkle C. M., Lanier W. L. Ten common questions (and their answers) about off-label drug use. Mayo Clinic proceedings, 2012, vol. 87, no. 10, pp. 982-990.